跳至主要内容
临床试验/JPRN-jRCT1080221028
JPRN-jRCT1080221028未知4 期

Postmarketing clinical study on AG-1749-clinical study on non-erosive reflux disease

Takeda Pharmaceutical Company Limited0 个研究点开始时间: 2010年2月24日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Subjects who have repeated acid reflux symptoms(chest burn or water brash)for two days or more in a week for 3 weeks prior to the running period.
  • 2.Subjects shown by endoscopy not to have erosive or ulcerative esophagitis
  • 3.Subjects have given written informed consent to participate in this study.

排除标准

  • 1.Subjects complicated with acute gastritis or chronic gastritis in the acute phase of worsening.
  • 2.Subject with a history of surgery (such as upper gastrointestinal tract dissection or vagotomy) that affects gastric acid secretion.

研究者

相似试验

Postmarketing clinical study on AG-1749-clinical... | 临床试验